|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||71.35 - 72.40|
|52 Week Range||34.20 - 121.80|
|Beta (5Y Monthly)||1.12|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 30, 2020|
|Forward Dividend & Yield||1.00 (1.45%)|
|Ex-Dividend Date||Jun 03, 2020|
|1y Target Est||144.23|
Syndax Pharmaceuticals reported on the first half-dozen patients to get a novel drug code-named SNDX-5613 that targets a mutation involved in some leukemias.
Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for On-Demand Viewing
Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on March 18th and 19th, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.
In PRESTO, almost all nurse participants (97.8%) reported a preference* for the Somatuline® Depot (lanreotide) redesigned pre-filled syringe
The results, which included preliminary safety and efficacy data, were presented as an oral presentation at the IASLC 2019 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Barcelona , 7-10 September 2019 .
Ipsen and Servier announce initial Phase 1/2 clinical data evaluating liposomal irinotecan (ONIVYDE®) as an investigational first-line treatment for metastatic pancreatic cancer at ESMO 21st World Congress ...